Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 58.6 TWD 0.69% Market Closed
Market Cap: 10.5B TWD

Wall Street
Price Targets

Price Targets Summary
Standard Chem & Pharm Co Ltd

There are no price targets for Standard Chem & Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Standard Chem & Pharm Co Ltd Competitors:
Price Targets
MDWD
Mediwound Ltd
39% Upside
ZYDUSLIFE
Zydus Lifesciences Ltd
14% Upside
214370
Caregen Co Ltd
20% Upside
ALKEM
Alkem Laboratories Ltd
8% Upside
1795
Lotus Pharmaceutical Co Ltd
33% Upside
NWRN
Newron Pharmaceuticals SpA
129% Upside
CORT
Corcept Therapeutics Inc
83% Upside

Revenue
Forecast

Revenue Estimate
Standard Chem & Pharm Co Ltd

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's revenue is 8%. The projected CAGR for the next 1 year is 7%.

8%
Past Growth
7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Standard Chem & Pharm Co Ltd

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's operating income is 16%. The projected CAGR for the next 1 year is 11%.

16%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Standard Chem & Pharm Co Ltd

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's net income is 13%.

13%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Standard Chem & Pharm Co Ltd's stock price target?
Not Available

Standard Chem & Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Standard Chem & Pharm Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's revenue is 8%. The projected CAGR for the next 1 year is 7%.

What is Standard Chem & Pharm Co Ltd's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's operating income is 16%. The projected CAGR for the next 1 year is 11%.

Back to Top